Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 14 of 14 publications.

Amin RP, Hamadeh HK, Bushel PR, Bennett L, Afshari CA, Paules RS. Genomic interrogation of mechanism(s) underlying cellular responses to toxicants. Toxicology. 2002 Dec 27;181-182:555-63.

Allen DB, Meltzer EO, Lemanske, Jr. RF, Philpot EE, Faris MA, Kral KM, Prillaman BA, Rickard KA. No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year. Allergy Asthma Proc. 2002 Nov;23(6):407-13.

Dykstra LA, Granger AL, Allen RM, Zhang X, Rice KC. Antinociceptive effects of the selective delta opioid agonist SNC80 alone and in combination with mu opioids in the squirrel monkey titration procedure. Psychopharmacology (Berl). 2002 Oct 1;163(3-4):420-9.

Irish WD, Neighbors DM, Grogg A, Lopez R, Girts T, Paul J. Performing epidemiological studies in schizophrenia: a propensity score model to predict selection of atypical antipsychotic. Poster presented at the 18th International Conference on Pharmacoepidemiology; August 2002. Edinburgh, Scotland.

Ratner PH, Howland, 3rd WC, Jacobs RL, Reed KD, Goode-Sellers ST, Prillaman BA, Philpot EE, Cook CK. Relief of sinus pain and pressure with fluticasone propionate aqueous nasal spray: a placebo-controlled trial in patients with allergic rhinitis. Allergy Asthma Proc. 2002 Jul;23(4):259-63.

Hamadeh HK, Bushel PR, Jayadev S, Martin K, DiSorbo O, Sieber S, Bennett L, Tennant R, Stoll R, Barrett JC, Blanchard K, Paules RS, Afshari CA. Gene expression analysis reveals chemical-specific profiles. Toxicol Sci. 2002 Jun 1;67(2):219-31.

Oh JS, Kucab JE, Bushel PR, Martin K, Bennett L, Collins J, DiAugustine RP, Barrett JC, Afshari CA, Dunn SE. Insulin-like growth factor-1 inscribes a gene expression profile for angiogenic factors and cancer progression in breast epithelial cells. Neoplasia. 2002 May 1;4(3):204-17.

Irish WD, Neighbors DM, Grogg A, Lopez R, Girts T, Degen K. Performing epidemiological studies in schizophrenia: a propensity score model to predict selection of atypical antipsychotic. Poster presented at the 2002 ISPOR 7th Annual International Meeting; May 2002. Arlington, VA. [abstract] Value Health. 2002 May; 5(1):216.

Allen RM, Granger AL, Dykstra LA. Dextromethorphan potentiates the antinociceptive effects of morphine and the delta-opioid agonist SNC80 in squirrel monkeys. J Pharmacol Exp Ther. 2002 Feb 1;300(2):435-41.

Irish WD, Neighbors D, Ortiz M. Evaluating therapeutic equivalence using meta analysis: implications for economic analysis. Poster presented at the Symposium on Meta Analysis of Medical Data sponsored by Mathematical Sciences Research Institute; 2002. Berkeley, CA.

Odom DM, Stivers J. The effects of September 11th on unit nonresponse in the national survey on drug use and health. Poster presented at the American Association for Public Opinion Research; 2002.

Packer L, Odom DM, Chromy J, Davis T, Gfroerer J. Changes in NHSDA measures of substance use initiation. In: Gfroerer J, Eyerman J, Chromy J, editors. Redesigning an ongoing national household survey: methodological issues. Rockville: United States. DHHS; 2002. p.185-220.

Eyerman J, Odom DM, Wu S, Butler D. Nonresponse in the 1999 NHSDA. In: Gfroerer J, Eyerman J, Chromy J, editors. Redesigning an ongoing national household survey: methodological issues. Rockville: United States. DHHS; 2002. p.23-51.

Hughes A, Chromy J, Giacoletti K, Odom DM. Impact of interviewer experience on respondent reports of substance use.. In: Gfroerer J, Eyerman J, Chromy J, editors. Redesigning an ongoing national household survey: methodological issues. Rockville: United States. DHHS; 2002. p.161-84.